Earnings Call Insights: Bionano Genomics (BNGO) Q4 2024 Management View CEO Erik Holmlin highlighted a strategic shift toward optimizing the utilization of existing optical genome mapping (OGM ...

Bionano Genomics Inc. (NASDAQ:BNGO) stock has tumbled to a 52-week low, touching down at $0.17, as the company faces a turbulent market environment. With a market capitalization of just $18.92 ...

Bionano Genomics (NASDAQ:BNGO) is preparing to release its quarterly earnings on Wednesday, 2025-05-14. Here's a brief overview of what investors should keep in mind before the announcement.

That’s particularly true for Bionano Genomics because it has changed in important ways. Most notably, the meteoric rise of BNGO stock has cleaned up the company’s balance sheet. Bionano has ...

Those who held BioNano Genomics (NASDAQ:BNGO) stock from late December until mid-February had a very happy start to 2021. Source: Connect world / S hutterstock.com BNGO stock rocketed from 51 ...

View Bionano Genomics, Inc. BNGO stock quote prices, financial information, real-time forecasts, and company news from CNN.

SAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported financial results and business achievements for the quarter ended September 30, ...

Shares of Bionano Genomics Inc. gained 10.3% in premarket trading on Friday following a week of heavy trading on the stock. The company's stock price has tripled since the start of the year ...

Should this divergence continue over the coming 3-5 years, investments in Bionano and many other genomics stocks may continue to prosper. Data by YCharts. The risks to the bull thesis.

SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ...